Publicacions en què col·labora amb Daniel Plano Amatriain (25)

2024

  1. Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

2023

  1. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment

    Molecules, Vol. 28, Núm. 15

  2. Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity

    Bioorganic Chemistry, Vol. 138

  3. Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe3O4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor

    Pharmaceuticals, Vol. 16, Núm. 7

  4. Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

    Antioxidants, Vol. 12, Núm. 1

2022

  1. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments

    Pharmaceuticals, Vol. 15, Núm. 12

  2. Unveiling a New Selenocyanate as a Multitarget Candidate with Anticancer, Antileishmanial and Antibacterial Potential

    Molecules, Vol. 27, Núm. 21

2021

  1. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5

  2. New amides and phosphoramidates containing selenium: Studies on their cytotoxicity and antioxidant activities in breast cancer

    Antioxidants, Vol. 10, Núm. 4

  3. New amides containing selenium as potent leishmanicidal agents targeting trypanothione reductase

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  4. New phosphoramidates containing selenium as leishmanicidal agents

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 10

  5. Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3197-3209

  6. Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and in Vivo Studies

    ACS Infectious Diseases, Vol. 7, Núm. 6, pp. 1727-1738

2020

  1. Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates

    Bioorganic and Medicinal Chemistry Letters, Vol. 30, Núm. 17

2017

  1. Library of seleno-compounds as novel agents against Leishmania species

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 6

  2. Selenium entities: Promising scaffolds for the treatment of cancer and leishmania

    Current Organic Synthesis, Vol. 14, Núm. 8, pp. 1075-1081

2016

  1. Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 6, pp. 3802-3812

2015

  1. Leishmanicidal activities of novel methylseleno-imidocarbamates

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 9, pp. 5705-5713

  2. Molecular descriptors calculation as a tool in the analysis of the antileishmanial activity achieved by two series of diselenide derivatives. An insight into its potential action mechanism

    Journal of Molecular Graphics and Modelling, Vol. 60, pp. 63-78

2014

  1. A dihydroselenoquinazoline inhibits S6 ribosomal protein signalling, induces apoptosis and inhibits autophagy in MCF-7 cells

    European Journal of Pharmaceutical Sciences, Vol. 63, pp. 87-95